Clinical Aspects of Melatonin Intervention in Alzheimer's Disease Progression

E-ISSN： 1875-6190|8|3|218-227

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.8, Iss.3, 2010-01, pp. : 218-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neurobiological aspects of Alzheimer's disease

By Chopra Kanwaljit Misra Shubham Kuhad Anurag

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 5, 2011-05 ,pp. : 535-555

Informa Healthcare

Access to resources Recommend Favorite

Slowing progression in Alzheimer's disease: potential of `Cerebrolysin'

Inpharma, Vol. 1, Iss. 1265, 2000-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Antigonadotropins: A Novel Strategy to Halt Alzheimer's Disease Progression

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 685-690

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Contribution to Alzheimer Disease: Predictors of Rapid Progression

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 4, 2013-06 ,pp. : 532-537

Bentham Science Publishers

Access to resources Recommend Favorite

Is an effective immune intervention for Alzheimer's disease in prospect?

By Esiri M.M.

Trends in Pharmacological Sciences, Vol. 22, Iss. 1, 2001-01 ,pp. : 2-3

Elsevier

Access to resources Recommend Favorite